MedPath

A Comparison of Epidural Block With Adding Sciatic Block to Continuous Femoral Block in Total Knee Arthroplasty

Not Applicable
Conditions
Postoperative Pain
Interventions
Device: epidural infusion
Device: femoral sciatic
Registration Number
NCT02235506
Lead Sponsor
Yeungnam University College of Medicine
Brief Summary

The investigators compared continuous epidural infusion with combined continuous femoral and single-shot sciatic nerve blocks. The primary outcome was the incidence of side effects, and secondary outcomes were pain relief, motor blockade,morphine consumption, and rehabilitation indices.

Detailed Description

The parcicipants were randomly assingned to epidural infusion group and femoral sciatic block. In epidural infusion group, a lumbar epidural catheter was placed at the L3-4 level using loss-ofresistance procedure. ropivacaine 0.2% and fentayl 2mcg/ml were infused at a rate of 5ml/hr from the end of operation. In femoral sciatic group, the femoral and sciatic nerve are located using ultrasound and 0.2% ropivacain is injected. A catheter is inserted to femoral nerve. From the end of operation, 0.2% ropivacaine was infused through the femoral catheter at a rate of 5ml/hr. The incidence of side effects is measured.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • American Society of Anesthesiologists Physical Status Classification I-II
  • total knee arthroplasty
  • 18-90 years
Exclusion Criteria
  • allergic to the local anesthetics
  • cognitive impairment such as dementia
  • coagulopathy
  • motor and sensory impairment
  • patient refusal
  • BMI >39

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
epidural infusionepidural infusionIn epidural infusion group, a lumbar epidural catheter was placed at the L3-4 level using loss-ofresistance procedure. ropivacaine 0.2% and fentayl 2mcg/ml were infused at a rate of 5ml/hr from the end of operation,
femoral sciaticfemoral sciaticIn femoral sciatic group, the femoral and sciatic nerve are located using ultrasound and 0.2% ropivacain is injected. A catheter is inserted to femoral nerve. From the end of operation, 0.2% ropivacaine was infused through the femoral catheter at a rate of 5ml/hr.
Primary Outcome Measures
NameTimeMethod
the incidence of side effectsduring 5 days after the end of operation

Side effects: The patients were asked to their experience of dizziness, sedation, nausea/vomiting (PONV), and pruritus. Urinary retention: bladder volume was measured by ultrasonography and if the volume was more than 400 mL and if the patient was unable to void spontaneously, single catheterization was performed.

Secondary Outcome Measures
NameTimeMethod
Painduring 5 days after the end of operation

Pain according to visual analogue scale at rest and on mobilization.

Motor blockade at rest and on mobilizationduring 5 days after the end of operation

Motor blockade is estimated using a modified Bromage scale

Trial Locations

Locations (1)

Department of Anesthesiology and Pain Medicine, Yeungnam University hospital

🇰🇷

Daegu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath